These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6862789)

  • 1. The detection of fibrinogen (or FgDP)-protamine sulphate complex in vitro and in the circulating blood.
    Kosugi T; Takagi I; Kinjo K; Aratake Y; Ohtaki S; Mihara H
    Int J Tissue React; 1983; 5(1):47-53. PubMed ID: 6862789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interaction of fibrinogen and fibrin with protamine sulfate].
    Mikhalovskaia LI; Varetskaia TV; Belitser VA
    Ukr Biokhim Zh (1978); 1988; 60(4):3-9. PubMed ID: 3188253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance of plasma-protein paracoagulation test in the diagnosis of thromboembolic the disease].
    Braun P; Meskó E; Gedeon A
    Z Gesamte Inn Med; 1976 Sep; 31(18):758-9. PubMed ID: 1007337
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protamine sulphate inhibits platelet membrane glycoprotein Ib-von Willebrand factor activity.
    Barstad RM; Stephens RW; Hamers MJ; Sakariassen KS
    Thromb Haemost; 2000 Feb; 83(2):334-7. PubMed ID: 10739395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoelectrophoretic studies on the kinetics of plasmic degradation of human fibrinogen.
    Braude R; Altman R; Rouvier J; Aguilar N
    Thromb Haemost; 1977 Feb; 37(1):136-43. PubMed ID: 576511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of the in vitro and in vivo thrombogenic activity of factor IX concentrates using stasis (Wessler) and non-stasis rabbit models.
    Prowse CV; Williams AE
    Thromb Haemost; 1980 Oct; 44(2):81-6. PubMed ID: 6779401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation and detection of fibrinogen derived complexes.
    Latallo ZS
    Thromb Diath Haemorrh; 1975 Dec; 34(3):677-85. PubMed ID: 1209540
    [No Abstract]   [Full Text] [Related]  

  • 8. Complex-formation between the fibrin-derived plasmic fragments DD and E demonstrated by crossed immunoelectrophoresis.
    Gogstad GO; Brosstad F
    Thromb Res; 1983 Jun; 30(5):441-8. PubMed ID: 6225217
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protamine interacts with the D-domains of fibrinogen.
    Okano K; Saito Y; Matsushima A; Inada Y
    Biochim Biophys Acta; 1981 Dec; 671(2):164-7. PubMed ID: 6173066
    [No Abstract]   [Full Text] [Related]  

  • 10. Fibrinolysis and fibrinogenolysis in patients with thrombotic disease.
    Takahashi H; Wada K; Hanano M; Niwano H; Takizawa S; Yazawa Y; Shibata A
    Blood Coagul Fibrinolysis; 1992 Apr; 3(2):193-6. PubMed ID: 1606291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Fluctuation of plasma levels of fibrinogen degradation products, fibrin degradation products and total fibrin/fibrinogen degradation products in patients with DIC].
    Isogai N; Kuroso K; Fujimaki M; Yorifuji H; Fukutake K
    Rinsho Byori; 1993 Dec; 41(12):1349-52. PubMed ID: 8295346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laboratory identification of intravascular coagulation. The serial dilution protamine sulfate test for the detection of fibrin monomer and fibrin degradation products.
    Niewiarowski S; Gurewich V
    J Lab Clin Med; 1971 Apr; 77(4):665-76. PubMed ID: 4928905
    [No Abstract]   [Full Text] [Related]  

  • 13. Fibrinogen catabolism within the procoagulant VX-2 tumor of rabbit lung in vivo: Effluxing fibrin(ogen) fragments contain antiangiogenic activity.
    Hatton MW; Southward SM; Legault KJ; Ross BL; Clarke BJ; Bajzar L; Blajchman MA; Singh G; Richardson M
    J Lab Clin Med; 2004 Apr; 143(4):241-54. PubMed ID: 15085083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An immunonephelometric micromethod of determining the levels of fibrin-fibrinogen degradation products].
    Ivanov EP; Tsvirko DG
    Lab Delo; 1989; (10):12-5. PubMed ID: 2481061
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A serial dilution protamine sulphate test for detecting fibrin degradation products.
    Schorn D
    S Afr Med J; 1973 Feb; 47(7):263-5. PubMed ID: 4689012
    [No Abstract]   [Full Text] [Related]  

  • 16. [Interaction of low density lipoproteins with fibrinogen and basic proteins].
    Skrzydlewski Z; Wiśniewski L; Głowiński S; Worowski K
    Patol Pol; 1979; 30(3):415-20. PubMed ID: 232260
    [No Abstract]   [Full Text] [Related]  

  • 17. [Role of Kupffer cells and hepatocytes in fibrinogen catabolism].
    Davydov VS; Subkhankulova FB; Litvinov RI; Zubairov DM
    Vopr Med Khim; 1982; 28(4):83-6. PubMed ID: 7113060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of two methods for estimating plasma fibrinogen and the effect of epsilon aminocaproic acid and protamine.
    Giddings JC; Bloom AL
    J Clin Pathol; 1971 Jul; 24(5):467-71. PubMed ID: 5571839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protamine sulphate used in combination with thrombin to remove fibrinogen prior to electrophoresis of heparinised plasma.
    Wright E; Briscoe M; McGing P; Maguire S
    Br J Biomed Sci; 1997 Jun; 54(2):152. PubMed ID: 9231462
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of BAY 41-2272 in the pulmonary hypertension induced by heparin-protamine complex in anaesthetized dogs.
    Freitas CF; Morganti RP; Annichino-Bizzacchi JM; De Nucci G; Antunes E
    Clin Exp Pharmacol Physiol; 2007; 34(1-2):10-4. PubMed ID: 17201729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.